Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Cerebral amyloid angiopathy (CAA) is present in over half of the elderly population and in 80–90% of Alzheimer’s disease (AD) patients. CAA is defined by the deposition of beta amyloid (Aβ) in small cerebral arteries and capillaries. Cardiovascular risk factors are associated with an increased incidence of CAA. We utilized 18-month-old endothelial nitric oxide synthase (eNOS) heterozygous knockout ( +/− ) mice, a clinically relevant model of endothelial dysfunction, to examine the role of endothelial nitric oxide (NO) in vascular Aβ accumulation. eNOS +/− mice had significantly higher vascular levels of Aβ40 ( P < 0.05). Aβ42 was not detected. There was no difference in Aβ in brain tissue. Amyloid precursor protein and β-site APP cleavage enzyme 1 protein levels were unaltered, while levels of the α-secretase enzyme, a disintegrin and metalloproteinase 10, were significantly lower in eNOS + /− microvascular tissue ( P < 0.05). Insulin degrading enzyme and low-density lipoprotein receptor-related protein 1 were significantly increased in eNOS +/− microvascular tissue, most likely an adaptive response to locally higher Aβ concentrations. Lastly, catalase and CuZn superoxide dismutase were significantly elevated in eNOS +/− microvascular tissue ( P < 0.05). These data demonstrate decreased availability of endothelial NO leads to increased cerebrovascular concentration of Aβ along with compensatory mechanisms to protect the vasculature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Choi, J. Y., Yeo, I. J., Kim, K. C., Choi, W. R., Jung, J.-K., Han, S.-B., & Hong, J. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1269-3 · Cited by 64
RetractedZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 1×
“This reflects decreased microvascular expression of eNOS protein as eNOS expression is restricted to endothelial cells.(26,27) No compensatory changes in other NOS isoforms were detected (Supplemental Figure 4(a) and (c) and (d); P> 0.”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135 · cited 1×
“Importantly, TXA2 is a powerful vasoconstrictor and stimulator of platelet aggregation.(81,82) Loss of endothelial NO and the resulting increased production of TXA2 puts the vasculature at greater risk of thrombotic 400 Journal of Cerebral Blood Flow & Metabolism 40(2)”
BackgroundSuperoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
Fukai, T., & Ushio-Fukai, M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3999 · Cited by 1,983
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071 · cited 2×
“CAA is characterized by the deposition of beta amyloid (Ab) in small cerebral arteries, arterioles, and capillaries.(1,4) The exact mechanism and source of the increased Ab within the cerebral vessel wall are unknown.”
BackgroundLammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 975 · cited 1×
“Interestingly, we did observe decreased expression of mature ADAM10, the primary a-secretase enzyme.(24,25) Endothelial NO may affect transcription or post translational modification of ADAM10 protein.”
Background
Research works printed but not linked: 1
- Suzuki N, 1994, Am J Pathol, 145, 452
Cited by
Zlokovic, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S., McKee, A., Snyder, H., Greenberg, S. M., Yaffe, K., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12157 · Cited by 232
Yang, Q. Z., Wei, X., Deng, B., Chang, Z., Jin, D., Huang, Y., Zhang, J. H., Yenari, M. A., Jin, K., & Wang, Q. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105750 · Cited by 142
“mechanisms underlying Aβ clearance in CSVD is that low-density lipoprotein receptor-related protein-1 (LRP1) mediates the active transcytosis of Aβ at the ECs and pericytes (Austin and Katusic, 2020).”
BackgroundContributions of Aging to Cerebral Small Vessel Disease
De Silva, T. M., & Faraci, F. M. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034338 · Cited by 122
“The phenotype seen in these mice is relevant to SVD and its consequences and includes microthrombi, increased levels of vascular β-amyloid, degeneration of vascular muscle, microbleeds, and reductions in cognition (Figures 1 and 3) (70, 71).”
BackgroundRole of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases
Pál, É., Ungvari, Z. I., Benyó, Z., & Várbíró, S. (2023) · Nutrients · doi:10.3390/nu15020334 · Cited by 130
Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
Gatti, L., Tinelli, F., Scelzo, E., Arioli, F., Di Fede, G., Obici, L., Pantoni, L., Giaccone, G., Caroppo, P., Parati, E. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103435 · Cited by 90
“processing of APP in both human cells and mouse cerebrovascular tissue [142] and of the angiotensin receptor blockers (i.”
Background
Metadata
- Authors
- Austin, S. A., & Katusic, Z. S.
- Affiliations
- Mayo Clinic (US)
- Departments of Anesthesiology and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2019-01-07
- Volume
- 40
- Issue
- 2
- Pages
- 392-403
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC7370614
- OpenAlex
- W2909251003
- Cited by
- 52
- References
- 83
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 9 · 2020: 5 · 2019: 2
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL131515)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- cerebral amyloid angiopathy, amyloid-beta, endothelial nitric oxide, endothelial nitric oxide synthase, eNOS knockout mice, Alzheimer's disease, amyloid precursor protein, ADAM10, alpha-secretase, insulin-degrading enzyme, LRP1, antioxidant enzymes, catalase, superoxide dismutase, endothelial dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Brain, Endothelium, Vascular, Nitric Oxide, Peptide Fragments, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Mice, Knockout, Mice, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid. https://app.cochat.ai/papers/10.1177/0271678x18822474
- The paper
- Austin, S. A., & Katusic, Z. S. (2020). Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x18822474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.